Atopic Dermatitis Skin Clearance Maintained Over 3 Years With Lebrikizumab
Written by
American Journal Managed Care
Published
0
comments
0
min
Lebrikizumab shows sustained efficacy and safety in managing moderate to severe atopic dermatitis over 3 years, reducing the need for rescue therapies.